Millendo Therapeutics Inc (MLND) |
|
1.86 0.01 (0.54%)
|
08-13 16:00 |
|
Open: |
1.87 |
Pre. Close: |
1.85 |
|
High:
|
1.87 |
Low:
|
1.82 |
|
Volume:
|
255,122 |
Market Cap:
|
35M |
|
|
|
|
Millendo Therapeutics, Inc., a late-stage biopharmaceutical company, engages in the development of various treatments for orphan endocrine diseases in the United States. The company's lead product candidates include livoletide, a potential treatment for Prader-Willi syndrome; and nevanimibe, a potential treatment for patients with classic congenital adrenal hyperplasia. Millendo Therapeutics, Inc. is headquartered in Ann Arbor, Michigan. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.872 - 1.881 |
1.881 - 1.889 |
|
Low:
|
1.798 - 1.809 |
1.809 - 1.818 |
|
Close:
|
1.844 - 1.861 |
1.861 - 1.875 |
|
Technical analysis |
as of: 2020-08-13 4:36:21 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 2.50 One year: 2.92 |
| Support: |
Support1: 1.78 Support2: 1.55 |
| Resistance: |
Resistance1: 2.14 Resistance2: 2.50 |
| Pivot: |
1.84  |
| Moving Average: |
MA(5): 1.88 MA(20): 1.85
MA(100): 2.18 MA(250): 5.21 |
| MACD: |
MACD(12,26): -0.01 Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 45.18 %D(3): 44.29 |
| RSI: |
RSI(14): 49.86 |
| 52-week: |
High: 9.88 Low: 1.26 Change(%): -73.4 |
| Average Vol(K): |
3-Month: 143336 10-Days: 45495 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.MLND has closed below upper band by 43.3%. Bollinger Bands are 85.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to MLND's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 12 Aug 2020
Analysts Offer Insights on Healthcare Companies: Millendo Therapeutics (NASDAQ: MLND) and Entasis Therapeutics Holdings (NASDAQ: ETTX) - Analyst Ratings
Mon, 10 Aug 2020
Earnings Scorecard & Analyst Reports for Millendo Therapeutics (NASDAQ:MLND) - Stock Market Daily
Mon, 10 Aug 2020
Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results - Odessa American
Tue, 28 Jul 2020
Here is a bargain stock you should look at : Millendo Therapeutics, Inc. (MLND) - Marketing Sentinel
Mon, 27 Jul 2020
Millendo Therapeutics, Inc. (MLND) Everything Investors Need To Know - The News Heater
Thu, 23 Jul 2020
Millendo Therapeutics Inc. (MLND) 14-day ATR is 0.23: This Stock is Set to Soar Above its Peers - News Daemon
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
19 |
| Shares Float (M) |
13 |
|
% Held by Insiders
|
11.30 |
|
% Held by Institutions
|
65.47 |
|
Shares Short (K)
|
1,000 |
|
Shares Short P. Month (K)
|
561 |
Stock Financials |
|
EPS
|
-3.084 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
2.830 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-41.2 |
|
Return on Equity (ttm)
|
-78.1 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
-2.461 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-41 |
|
Levered Free Cash Flow (M)
|
-23 |
Stock Valuations |
|
PE Ratio
|
-0.60 |
|
PEG Ratio
|
|
|
Price to Book value
|
0.66 |
|
Price to Sales
|
|
|
Price to Cash Flow
|
-0.87 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
